Variant report

Variant	rs3774751
Chromosome Location	chr3:50209053-50209054
allele	G/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	FOXA2	chr3:50208919-50209447	HepG2	liver:	n/a	chr3:50209108-50209120
2	FOXA1	chr3:50208782-50209517	HepG2	liver:	n/a	chr3:50209108-50209120
3	BHLHE40	chr3:50208984-50209577	HepG2	liver:	n/a	n/a
4	SP1	chr3:50208837-50209536	HepG2	liver:	n/a	chr3:50209094-50209108 chr3:50208931-50208940 chr3:50208930-50208940 chr3:50209217-50209230 chr3:50208929-50208941 chr3:50209098-50209108 chr3:50208930-50208944 chr3:50208930-50208939 chr3:50208929-50208941 chr3:50209098-50209107 chr3:50209473-50209487
5	EP300	chr3:50208804-50209676	HepG2	liver:	n/a	chr3:50209111-50209121 chr3:50209587-50209603
6	MAX	chr3:50208875-50209870	HepG2	liver:	n/a	chr3:50209651-50209667 chr3:50209660-50209670
7	ZEB1	chr3:50208098-50209914	HepG2	liver:	n/a	chr3:50209188-50209199 chr3:50209187-50209199 chr3:50209198-50209210
8	FOXA2	chr3:50209014-50209233	A549	lung:	n/a	chr3:50209108-50209120
9	EP300	chr3:50208836-50209543	HepG2	liver:	n/a	chr3:50209111-50209121
10	TCF12	chr3:50208898-50209498	ECC-1	luminal epithelium:	n/a	chr3:50209192-50209199
11	TCF12	chr3:50209033-50209494	HepG2	liver:	n/a	chr3:50209192-50209199
12	CEBPD	chr3:50208868-50209496	HepG2	liver:	n/a	n/a
13	TCF7L2	chr3:50208942-50209717	PANC-1	pancreas:	n/a	chr3:50209281-50209290 chr3:50209278-50209294 chr3:50209279-50209293 chr3:50209278-50209294 chr3:50209282-50209292
14	RCOR1	chr3:50208965-50209642	HepG2	liver:	n/a	n/a
15	SPI1	chr3:50208982-50209107	K562	blood:	n/a	chr3:50209068-50209081 chr3:50209084-50209097 chr3:50209071-50209078
16	JUND	chr3:50208970-50209406	HepG2	liver:	n/a	n/a
17	MAZ	chr3:50208613-50209494	HepG2	liver:	n/a	n/a
18	FOXA1	chr3:50208974-50209421	HepG2	liver:	n/a	chr3:50209108-50209120
19	NFIC	chr3:50208883-50209759	HepG2	liver:	n/a	n/a
20	TCF7L2	chr3:50208888-50209737	HepG2	liver:	n/a	chr3:50209281-50209290 chr3:50209278-50209294 chr3:50209279-50209293 chr3:50209278-50209294 chr3:50209282-50209292
21	MYBL2	chr3:50208899-50209518	HepG2	liver:	n/a	n/a
22	HNF4G	chr3:50208918-50209524	HepG2	liver:	n/a	chr3:50209311-50209333 chr3:50209450-50209472
23	MBD4	chr3:50208990-50209521	HepG2	liver:	n/a	n/a
24	HDAC2	chr3:50208796-50209570	HepG2	liver:	n/a	chr3:50209111-50209120
25	CEBPB	chr3:50209051-50209486	HepG2	liver:	n/a	n/a
26	ZBTB7A	chr3:50208751-50209554	HepG2	liver:	n/a	chr3:50208956-50208965
27	NR2F2	chr3:50208872-50209684	HepG2	liver:	n/a	n/a
28	MAX	chr3:50208988-50209787	HepG2	liver:	n/a	chr3:50209651-50209667 chr3:50209660-50209670
29	HNF4A	chr3:50208879-50209469	HepG2	liver:	n/a	chr3:50209311-50209333 chr3:50209277-50209292
30	FOXA1	chr3:50208842-50209504	HepG2	liver:	n/a	chr3:50209108-50209120
31	TCF7L2	chr3:50208843-50209771	Hela-S3	cervix:	n/a	chr3:50209281-50209290 chr3:50209278-50209294 chr3:50209279-50209293 chr3:50209278-50209294 chr3:50209282-50209292
32	FOXA1	chr3:50208922-50209531	HepG2	liver:	n/a	chr3:50209108-50209120
33	NFIC	chr3:50208928-50209407	ECC-1	luminal epithelium:	n/a	n/a
34	JUND	chr3:50208942-50209469	HepG2	liver:	n/a	n/a
35	FOSL2	chr3:50208891-50209486	HepG2	liver:	n/a	n/a
36	HNF4A	chr3:50208963-50209515	HepG2	liver:	n/a	chr3:50209311-50209333 chr3:50209450-50209472 chr3:50209277-50209292
37	BHLHE40	chr3:50209032-50209391	HepG2	liver:	n/a	n/a
38	YY1	chr3:50208973-50209664	HepG2	liver:	n/a	n/a
39	TCF12	chr3:50208887-50209395	HepG2	liver:	n/a	chr3:50209192-50209199
40	POLR2A	chr3:50208864-50209390	Hela-S3	cervix:	n/a	n/a
41	ZBTB7A	chr3:50208839-50209560	HepG2	liver:	n/a	chr3:50208956-50208965
42	BHLHE40	chr3:50209049-50209350	HepG2	liver:	n/a	n/a
43	MYBL2	chr3:50208902-50209569	HepG2	liver:	n/a	n/a
44	MXI1	chr3:50209004-50209472	HepG2	liver:	n/a	n/a
45	CEBPB	chr3:50209028-50209444	HepG2	liver:	n/a	n/a
46	TEAD4	chr3:50208898-50209620	HepG2	liver:	n/a	n/a
47	RXRA	chr3:50208854-50209545	HepG2	liver:	n/a	chr3:50209320-50209329 chr3:50209323-50209334 chr3:50209465-50209479 chr3:50209322-50209335 chr3:50209322-50209335
48	CEBPB	chr3:50208949-50209420	HepG2	liver:	n/a	n/a
49	NFIC	chr3:50208915-50209529	HepG2	liver:	n/a	n/a
50	TCF12	chr3:50208730-50209400	ECC-1	luminal epithelium:	n/a	chr3:50209192-50209199

No.	Distal block	Cell Line	Cell type
1	chr3:50194586..50199661-chr3:50206741..50210376,5	K562	blood:
2	chr2:47894703..47895203-chr3:50208625..50209338,2	NB4	blood:
3	chr3:50164983..50167115-chr3:50208238..50210374,2	MCF-7	breast:
4	chr3:50191401..50200098-chr3:50206213..50213809,14	MCF-7	breast:
5	chr3:50208138..50210089-chr3:50211604..50213556,2	MCF-7	breast:

Variant related genes	Relation type
MIR566	TF binding region
SEMA3F	TF binding region
ENSG00000001617	Chromatin interaction
ENSG00000235016	Chromatin interaction

Extended variants
information (count: 43 )
Associated
traits (count: 10 )

rSNPs within LD-proxies of this variant (count:15)

rs_ID	r²[population]
rs11711407	0.80[AMR][1000 genomes];0.89[ASN][1000 genomes]
rs11714286	0.81[AMR][1000 genomes];0.85[ASN][1000 genomes]
rs11714799	0.81[AMR][1000 genomes];0.91[ASN][1000 genomes]
rs11717349	0.81[AMR][1000 genomes];0.91[ASN][1000 genomes]
rs13085567	0.83[AMR][1000 genomes];0.90[ASN][1000 genomes]
rs2073726	0.81[AMR][1000 genomes];0.91[ASN][1000 genomes]
rs2526383	0.84[ASN][1000 genomes]
rs34877766	0.90[ASN][1000 genomes]
rs3755831	0.88[ASN][1000 genomes]
rs3774745	0.85[AFR][1000 genomes];0.94[AMR][1000 genomes];0.97[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs3774749	0.91[AFR][1000 genomes];0.95[AMR][1000 genomes];0.98[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs3774750	0.94[AFR][1000 genomes];0.98[AMR][1000 genomes];0.97[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs4688745	0.81[ASN][1000 genomes]
rs67627084	0.83[AMR][1000 genomes];0.93[ASN][1000 genomes]
rs9858059	0.90[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:28 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv834690	chr3:50101835-50267584	Strong transcription Weak transcription Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	24 gene(s)	inside rSNPs	diseases
2	nsv515986	chr3:50104307-50267584	Bivalent Enhancer Strong transcription Weak transcription Flanking Bivalent TSS/Enh Active TSS Enhancers Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	24 gene(s)	inside rSNPs	diseases
3	nsv432418	chr3:50114496-50224196	Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers Weak transcription Strong transcription Flanking Active TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	18 gene(s)	inside rSNPs	diseases
4	nsv1001775	chr3:50129479-50311666	Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Strong transcription Weak transcription Transcr. at gene 5' and 3' Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	42 gene(s)	inside rSNPs	diseases
5	nsv876768	chr3:50144951-50267584	Bivalent/Poised TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription Bivalent Enhancer Strong transcription Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	17 gene(s)	inside rSNPs	diseases
6	nsv523662	chr3:50144951-50584999	Flanking Bivalent TSS/Enh Weak transcription Genic enhancers Bivalent Enhancer Strong transcription Transcr. at gene 5' and 3' Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	101 gene(s)	inside rSNPs	diseases
7	nsv1013949	chr3:50151712-50339163	Flanking Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Active TSS Bivalent Enhancer Genic enhancers Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
8	nsv590250	chr3:50153356-50332697	Weak transcription Enhancers Strong transcription Flanking Active TSS Genic enhancers Bivalent/Poised TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	43 gene(s)	inside rSNPs	diseases
9	nsv876769	chr3:50155468-50408398	Active TSS Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent/Poised TSS Strong transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	94 gene(s)	inside rSNPs	diseases
10	esv1821728	chr3:50156142-50657253	Strong transcription Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	109 gene(s)	inside rSNPs	diseases
11	esv1793751	chr3:50157364-50476363	Weak transcription Enhancers Transcr. at gene 5' and 3' Strong transcription Flanking Bivalent TSS/Enh Genic enhancers Flanking Active TSS Active TSS Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	98 gene(s)	inside rSNPs	diseases
12	esv1828162	chr3:50157364-50506151	Enhancers Genic enhancers Transcr. at gene 5' and 3' Flanking Active TSS Active TSS Weak transcription Strong transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	98 gene(s)	inside rSNPs	diseases
13	nsv590251	chr3:50158774-50337422	Active TSS Strong transcription Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
14	nsv470561	chr3:50158774-50584999	Flanking Active TSS Enhancers Weak transcription Genic enhancers Active TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	99 gene(s)	inside rSNPs	diseases
15	nsv876770	chr3:50158774-50609624	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	103 gene(s)	inside rSNPs	diseases
16	nsv523560	chr3:50172397-50339163	Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Genic enhancers Strong transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
17	nsv460529	chr3:50178011-50324672	Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers Strong transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
18	nsv460530	chr3:50178011-50324672	Bivalent Enhancer Weak transcription Flanking Active TSS Enhancers Strong transcription Active TSS Transcr. at gene 5' and 3' Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
19	nsv590252	chr3:50178011-50324672	Enhancers Bivalent Enhancer Strong transcription Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
20	nsv1002916	chr3:50187646-50311666	Enhancers Flanking Bivalent TSS/Enh Weak transcription Strong transcription Flanking Active TSS Genic enhancers Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
21	nsv536564	chr3:50187646-50311666	Flanking Active TSS Enhancers Weak transcription Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
22	nsv1014256	chr3:50187646-50339163	Enhancers Active TSS Strong transcription Weak transcription Genic enhancers Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
23	nsv536565	chr3:50187646-50339163	Flanking Active TSS Bivalent Enhancer Active TSS Strong transcription Enhancers Weak transcription Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
24	nsv1001993	chr3:50187646-50640808	Weak transcription Enhancers Flanking Active TSS Active TSS Genic enhancers Bivalent/Poised TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	104 gene(s)	inside rSNPs	diseases
25	nsv590253	chr3:50196418-50337422	Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Genic enhancers Transcr. at gene 5' and 3' Active TSS Enhancers Strong transcription Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
26	esv2757870	chr3:50198478-50371377	Genic enhancers Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Active TSS Bivalent/Poised TSS Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	74 gene(s)	inside rSNPs	diseases
27	esv2759148	chr3:50198478-50371377	Enhancers Weak transcription Genic enhancers Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Strong transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	74 gene(s)	inside rSNPs	diseases
28	nsv834692	chr3:50198485-50393464	Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Genic enhancers Bivalent Enhancer Active TSS Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	94 gene(s)	inside rSNPs	diseases

mRNA abundance (count:10)

SNP	Gene	Cis/trans	Tissue	Source
rs3774751	RBM6	cis	Artery Aorta	GTEx
rs3774751	RBM6	cis	Thyroid	GTEx
rs3774751	RBM6	cis	lung	GTEx
rs3774751	RBM6	cis	Nerve Tibial	GTEx
rs3774751	RBM6	cis	Whole Blood	GTEx
rs3774751	RBM6	Cis_1M	lymphoblastoid	RTeQTL
rs3774751	RBM6	cis	Esophagus Muscularis	GTEx
rs3774751	RBM6	cis	Heart Left Ventricle	GTEx
rs3774751	RBM6	cis	Esophagus Mucosa	GTEx
rs3774751	RBM6	cis	Artery Tibial	GTEx

Chromatin state (count:86 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:50195400-50210200	Genic enhancers	Fetal Stomach	stomach
2	chr3:50195400-50210600	Enhancers	Left Ventricle	heart
3	chr3:50195400-50210800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
4	chr3:50196200-50211600	Enhancers	Rectal Mucosa Donor 31	rectum
5	chr3:50197200-50211600	Genic enhancers	Esophagus	oesophagus
6	chr3:50199200-50209400	Enhancers	Placenta	Placenta
7	chr3:50200000-50209600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
8	chr3:50200000-50210400	Enhancers	Fetal Brain Male	brain
9	chr3:50200600-50211800	Enhancers	Right Ventricle	heart
10	chr3:50202000-50210600	Enhancers	A549	lung
11	chr3:50202200-50210400	Enhancers	Lung	lung
12	chr3:50202800-50211000	Enhancers	Fetal Muscle Leg	muscle
13	chr3:50203000-50210000	Enhancers	Duodenum Mucosa	Duodenum
14	chr3:50203400-50211400	Weak transcription	Placenta Amnion	Placenta Amnion
15	chr3:50203800-50210000	Genic enhancers	HMEC	breast
16	chr3:50204400-50211000	Weak transcription	H9 Cell Line	embryonic stem cell
17	chr3:50204600-50209600	Enhancers	HUVEC	blood vessel
18	chr3:50204600-50226600	Weak transcription	Brain Anterior Caudate	brain
19	chr3:50204800-50210400	Enhancers	Stomach Smooth Muscle	stomach
20	chr3:50204800-50210600	Genic enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
21	chr3:50204800-50211200	Weak transcription	Aorta	Aorta
22	chr3:50204800-50211800	Weak transcription	iPS-20b Cell Line	embryonic stem cell
23	chr3:50205000-50209200	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
24	chr3:50205000-50212800	Genic enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
25	chr3:50205400-50209200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
26	chr3:50205400-50210200	Genic enhancers	NHEK	skin
27	chr3:50205400-50211800	Enhancers	Stomach Mucosa	stomach
28	chr3:50205400-50226600	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
29	chr3:50205400-50226600	Weak transcription	Rectal Smooth Muscle	rectum
30	chr3:50205600-50211200	Weak transcription	HUES48 Cell Line	embryonic stem cell
31	chr3:50205600-50211400	Weak transcription	iPS-18 Cell Line	embryonic stem cell
32	chr3:50205800-50211800	Weak transcription	Fetal Kidney	kidney
33	chr3:50206400-50226600	Weak transcription	NHLF	lung
34	chr3:50206600-50211200	Weak transcription	Ovary	ovary
35	chr3:50206600-50211600	Genic enhancers	Breast Myoepithelial Primary Cells	Breast
36	chr3:50207000-50209200	Weak transcription	Sigmoid Colon	Sigmoid Colon
37	chr3:50207200-50209600	Weak transcription	Colon Smooth Muscle	Colon
38	chr3:50207200-50211600	Enhancers	Spleen	Spleen
39	chr3:50207600-50209800	Genic enhancers	ES-UCSF4 Cell Line	embryonic stem cell
40	chr3:50207600-50210200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
41	chr3:50208200-50209200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
42	chr3:50208200-50209400	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
43	chr3:50208200-50209800	Enhancers	Fetal Lung	lung
44	chr3:50208200-50210600	Enhancers	Fetal Heart	heart
45	chr3:50208200-50211200	Weak transcription	HUES64 Cell Line	embryonic stem cell
46	chr3:50208200-50211600	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
47	chr3:50208400-50209400	Enhancers	HSMMtube	muscle
48	chr3:50208400-50210600	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
49	chr3:50208400-50210600	Enhancers	Rectal Mucosa Donor 29	rectum
50	chr3:50208400-50211400	Enhancers	Colonic Mucosa	Colon

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links